{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:54Z","timestamp":1792806054338,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.diabres.2026.113613","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:46:31Z","timestamp":1791992791000},"page":"113613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Capturing human-machine interplay in automated insulin delivery systems through day-to-day variability of the automated correction index (ACI-V%)"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-4178","authenticated-orcid":false,"given":"Andrea","family":"Tumminia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6663-937X","authenticated-orcid":false,"given":"Giuseppe","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4104-1105","authenticated-orcid":false,"given":"Francesco","family":"Galeano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Oteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0558-5454","authenticated-orcid":false,"given":"Vincenzo","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-4525","authenticated-orcid":false,"given":"Roberto","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7049-1330","authenticated-orcid":false,"given":"Roberto","family":"Palazzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Gusmano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3563-6903","authenticated-orcid":false,"given":"Gianfranco","family":"Gruttadauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella Lo","family":"Presti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2194-4792","authenticated-orcid":false,"given":"Salvatore Scir\u00e8","family":"Calabrisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Anzaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Piticchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro La","family":"Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-5828","authenticated-orcid":false,"given":"Lucia","family":"Frittitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6950-335X","authenticated-orcid":false,"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113613_b0005","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113613_b0010","doi-asserted-by":"crossref","unstructured":"Diabetes* ADAPPC for, Bajaj M, McCoy RG, et al (2026) 7. Diabetes Technology: Standards of Care in Diabetes\u20142026. Diabetes Care 49:S150\u2013S165. doi: 10.2337\/DC26-S007.","DOI":"10.2337\/dc26-S007"},{"key":"10.1016\/j.diabres.2026.113613_b0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and Glycemic outcomes during the MiniMedTM advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/19322968231185115","article-title":"Real-world performance of first- versus second-generation automated insulin delivery systems on a pediatric population with type 1 diabetes: a one-year observational study","volume":"19","author":"Bombaci","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113613_b0025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJMc2315000","article-title":"Digital technology for diabetes","volume":"390","author":"Kinny-K\u00f6ster","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113613_b0030","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1056\/NEJMra2215899","article-title":"Digital TECHNOLOGY FOR DIABETES","volume":"389","author":"Hughes","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113613_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103190","article-title":"Efficacy of automated insulin delivery systems in people with type 1 diabetes: a systematic review and network meta-analysis of outpatient randomised controlled trials","volume":"82","author":"Stahl-Pehe","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.diabres.2026.113613_b0040","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/dom.15718","article-title":"Real-world glycaemic outcomes of automated insulin delivery in type 1 diabetes: a meta-analysis","volume":"26","author":"Yang","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113613_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/dmrr.2557","article-title":"Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial","volume":"31","author":"Tumminia","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabres.2026.113613_b0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/dia.2014.0242","article-title":"Continuous subcutaneous insulin infusion in Italy: third national survey","volume":"17","author":"Bruttomesso","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0055","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/PPA.S69482","article-title":"Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update","volume":"9","author":"Tumminia","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.diabres.2026.113613_b0060","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1007\/s00125-024-06165-w","article-title":"The role of automated insulin delivery technology in diabetes","volume":"67","author":"Boughton","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113613_b0065","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/193229680800200618","article-title":"Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?","volume":"2","author":"Monnier","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113613_b0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2026.113613_b0075","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113613_b0080","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1210\/jc.2014-2879","article-title":"Glucose fluctuations in association with oxidative stress among children with T1DM: comparison of different phases","volume":"100","author":"Meng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113613_b0085","doi-asserted-by":"crossref","DOI":"10.2174\/1573399816666200716201550","article-title":"Glycemic variability, oxidative stress, and impact on complications related to type 2 diabetes mellitus","volume":"17","author":"Valente","year":"2021","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.diabres.2026.113613_b0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2026.113613_b0095","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113613_b0100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13300-019-0619-1","article-title":"A view beyond HbA1c: role of continuous glucose monitoring","volume":"10","author":"Chehregosha","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0105","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113613_b0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s13300-021-01020-2","article-title":"A \u201cSlide Rule\u201d to adjust insulin dose using trend arrows in adults with type 1 diabetes: test in silico and in real life","volume":"12","author":"Bruttomesso","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0115","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1007\/s12325-025-03326-0","article-title":"Evaluation of Glycemia risk index and continuous glucose monitoring outcomes following the transition to an advanced hybrid closed-loop system in type 1 diabetes","volume":"42","author":"Al Hayek","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112476","article-title":"Effect of daily insulin delivery variability on glycemic outcomes in patients with type 1 diabetes mellitus using an automated insulin delivery system","volume":"229","author":"Papa","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113613_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112173","article-title":"The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy","volume":"224","author":"Tumminia","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113613_b0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/dia.2023.0319","article-title":"12-month efficacy of advanced hybrid closed-loop system in adult type 1 diabetes patients","volume":"26","author":"Nigi","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0135","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc18-2625","article-title":"Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery","volume":"42","author":"Dovc","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113613_b0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00592-024-02397-9","article-title":"Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems","volume":"62","author":"Borella","year":"2025","journal-title":"Acta Diabetol"},{"issue":"14","key":"10.1016\/j.diabres.2026.113613_b0145","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/jcm14248823","article-title":"Sex differences in continuous glucose monitoring metrics and glucose variability in subjects with type 1 diabetes treated with advanced hybrid closed loop therapy: an observational, retrospective, one-year follow-up study","volume":"14","author":"Conti","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2026.113613_b0150","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/dom.14807","article-title":"Predictors of time in target glucose range in real-world users of the MiniMed 780G system","volume":"24","author":"Casta\u00f1eda","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113613_b0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real world performance of the MiniMed 780G system: first report of outcomes from 4120 users","volume":"24","author":"Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/dia.2023.0453","article-title":"Early real-world performance of the MiniMed 780G advanced hybrid closed-loop system and recommended settings use in the United States","volume":"26","author":"Thrasher","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113613_b0165","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/dom.15023","article-title":"Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system","volume":"25","author":"Grassi","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113613_b0170","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/dom.16227","article-title":"MiniMed 780G system performance in older users with type 1 diabetes: real-world evidence and the case for stricter glycaemic targets","volume":"27","author":"Smaniotto","year":"2025","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:41:25Z","timestamp":1792802485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726005334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S0168822726005334"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113613","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capturing human-machine interplay in automated insulin delivery systems through day-to-day variability of the automated correction index (ACI-V%)","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113613"}}